Bridging, switching or drug holidays – how to treat a patient who stops natalizumab?
Joachim Havla,1 Ingo Kleiter,2 Tania Kümpfel11Institute of Clinical Neuroimmunology, Medical Campus Grosshadern, Ludwig Maximilians University, Munich, 2Department of Neurology, St Josef Hospital, Ruhr University, Bochum, GermanyAbstract: Natalizumab (NAT) was the first monoclonal antibody...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Dove Medical Press,
2013-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |